Yukti Medical Innovations Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 29-06-2024
- Paid Up Capital ₹ 0.20 M
as on 29-06-2024
- Company Age 14 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
About Yukti Medical Innovations
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Subramoney Parameswaran and Ganapathy Iyer serve as directors at the Company.
- CIN/LLPIN
U51397KA2010PTC056240
- Company No.
056240
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Yukti Medical Innovations Private Limited offer?
Yukti Medical Innovations Private Limited offers a wide range of products and services, including Reference Books & Study Material, Reference Books.
Who are the key members and board of directors at Yukti Medical Innovations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramoney Parameswaran  | Director | 16-Jun-2014 | Current |
| Ganapathy Iyer | Director | 20-Mar-2023 | Current |
Financial Performance of Yukti Medical Innovations.
Yukti Medical Innovations Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Yukti Medical Innovations?
In 2017, Yukti Medical Innovations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zandig Tqm Solutions Private LimitedActive 26 years 5 monthsSubramoney Parameswaran and Ganapathy Iyer are mutual person
- Zandig Knowledge Management Private LimitedActive 17 years 24 days
Subramoney Parameswaran and Ganapathy Iyer are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yukti Medical Innovations?
Unlock and access historical data on people associated with Yukti Medical Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yukti Medical Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yukti Medical Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
